Publisher: DelveInsight
Category: Diseases & Conditions

Diseases & Conditions market research reports by DelveInsight

(1,157 reports matching your criteria)
    • Psoriatic Arthritis - Pipeline Insight, 2024

      Psoriatic Arthritis - Pipeline Insight, 2024 DelveInsight’s, “Psoriatic Arthritis - Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Psoriatic Arthritis pipeline landscape. It covers the pipeline drug profiles, including clinical and noncl ... Read More

    • Hemophilia A - Market Insight, Epidemiology And Market Forecast - 2034

      Hemophilia A - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Usher Syndrome (USH) is the most common genetic condition responsible for combined loss of hearing and vision. Balance disorders and bilateral vestibular areflexia are also observed in some cases. Limited knowledge ... Read More

    • Aplastic Anemia - Market Insight, Epidemiology And Market Forecast - 2034

      Aplastic Anemia - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In the 7MM, United States accounted for the largest market size in 2023, with approximately USD ~190 million. Aplastic anemia is a rare and severe nonmalignant disease characterized by autoimmune destruction of ... Read More

    • CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Market Insight, Epidemiology And Market Forecast - 2032

      CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights In 2023, the market size of epidermolysis bullosa was highest in the US among the 7MM, accounting for approximately USD 1,300 million, which is further expected to increase by ... Read More

    • Pulmonary Arterial Hypertension Market Insight, Epidemiology And Market Forecast - 2034

      Pulmonary Arterial Hypertension Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the market size of myelofibrosis was highest in the US among the 7MM, accounting for approximately USD 1,400 million, which is further expected to increase by 2034. In the 7MM, JAKAFI/JAKA ... Read More

    • Diabetic Kidney Disease (DKD) - Market Insight, Epidemiology And Market Forecast - 2034

      Diabetic Kidney Disease (DKD) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In the 7MM, the United States accounted for the largest market size in 2023, with approximately USD 6,500 million. The disease is reported to occur in 20–50% of those living with diabetes and is t ... Read More

    • Ocular Melanoma - Market Insight, Epidemiology And Market Forecast - 2034

      Ocular Melanoma - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Stargardt disease, also known as Stargardt’s macular dystrophy or juvenile macular degeneration, is a rare genetic eye disease that happens when fatty material builds up on the macula — the small part of the ret ... Read More

    • Sleep Apnea Implants - Market Insights, Competitive Landscape and Market Forecast-2028

      Sleep Apnea Implants - Market Insights, Competitive Landscape and Market Forecast-2028 Sleep Apnea Implant Market By Product (Hypoglossal Nerve Stimulation Devices, Phrenic Nerve Stimulator Devices, And Others), Indication (Central Sleep Apnea And Obstructive Sleep Apnea), End-User (Hospital & Clini ... Read More

    • Autoimmune Diseases Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2028

      Autoimmune Diseases Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2028 Autoimmune Disease Diagnostics Market By Product (Reagents & Kits And Instruments), Disease Type (Localized Autoimmune Disease, And Systemic Autoimmune Disease), Test (Antinuclear Antibody Test, Aut ... Read More

    • Tuberculosis Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2028

      Tuberculosis Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2028 Tuberculosis Diagnostics Market By Product Type (Instruments And Assay, Kits, & Reagents), Test Type (Radiographic Test, Laboratory Test, Nucleic Acid Testing, Cytokine Detection Test, Drug Resistance Test, ... Read More

    • Triple Negative Breast Cancer (TNBC) - Market Insight, Epidemiology And Market Forecast - 2032

      Triple Negative Breast Cancer (TNBC) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights Breast cancer is a genetically and clinically heterogeneous disease with multiple subtypes. The classification of these subtypes has evolved over the years. The most common and widely accept ... Read More

    • Metastatic Non-Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast -2032

      Metastatic Non-Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast -2032 Key Highlights NSCLC market size has seen a revolutionary change in the last decade owing to the increase in incident case of NSCLC, continuous uptake of approved therapies mainly immune checkpoint inhibit ... Read More

    • HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032

      HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights Recent advancements in HER2 treatments have enhanced HER2-positive breast cancer management, yet relapse remains a primary challenge due to disease heterogeneity and drug resistance mechanisms. In 20 ... Read More

    • OCS-01 Emerging Drug Insight and Market Forecast − 2032

      OCS-01 Emerging Drug Insight and Market Forecast − 2032 “OCS-01 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about OCS-01 for acute ocular pain (AOP) in the eight major markets. A detailed picture of the OCS-01 for acute ocular pain in the 8MM, i.e., the U ... Read More

    • Metastatic Prostate Cancer - Market Insight, Epidemiology And Market Forecast - 2032

      Metastatic Prostate Cancer - Market Insight, Epidemiology And Market Forecast - 2032 DelveInsight's ""Metastatic Prostate Cancer - Market Insights, Epidemiology, and Market Forecast-2032"" report delivers an in-depth understanding of the metastatic prostate cancer, historical and forecasted epidemio ... Read More

    • Metastatic HR+/HER2− Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032

      Metastatic HR+/HER2− Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032 Key Highlights Breast cancer is a genetically and clinically heterogeneous disease with multiple subtypes. The HR+/HER2- subtype is the most common of all the breast cancer subtypes. The total market size in ... Read More

    • Non-metastatic Prostate Cancer (nmPC) - Market Insight, Epidemiology and Market Forecast -2032

      Non-metastatic Prostate Cancer (nmPC) - Market Insight, Epidemiology and Market Forecast -2032 Key Highlights Non-metastatic prostate cancer (nmPC) refers to prostate cancer that has not spread beyond the prostate gland and nearby lymph nodes. It is a localized form of prostate cancer. When prostate ... Read More

    • Chronic Hepatitis B - Market Insight, Epidemiology And Market Forecast - 2032

      Chronic Hepatitis B - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights People infected with Chronic Hepatitis B often have no symptoms, which may be the primary cause of the low diagnosis rate across the 7MM since many people go undiagnosed. In 2022, the market size of Chronic ... Read More

    • Postmenopausal osteoporosis - Pipeline Insight, 2023

      Postmenopausal osteoporosis - Pipeline Insight, 2023 DelveInsight’s, “Postmenopausal osteoporosis - Pipeline Insight, 2023,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Postmenopausal osteoporosis pipeline landscape. It covers the pipeline drug profiles, incl ... Read More

    • Triple Negative Breast Cancer Epidemiology Forecast - 2032

      Triple Negative Breast Cancer Epidemiology Forecast - 2032 Key Highlights Breast cancer is a genetically and clinically heterogeneous disease with multiple subtypes. The classification of these subtypes has evolved over the years. The most common and widely accepted classification of breast cancer i ... Read More

    • Insulin Delivery Device - Global Market Insights, Competitive Landscape, and Market Forecast - 2028

      Insulin Delivery Device - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 Insulin Delivery Devices Market By Product Type (Insulin Syringes, Insulin Pens, Insulin Pumps [Tethered/External Pumps and Patch Pumps], Insulin Injectors, and Others), End-User (Homecare Settings, D ... Read More

    • Pain Management Devices - Global Market Insights, Competitive Landscape, and Market Forecast - 2028

      Pain Management Devices - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 Pain Management Devices Market By Type Of Devices (Neuromodulation and Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Ra ... Read More

    • Still’s Disease- Pipeline Insight, 2023

      Still’s Disease- Pipeline Insight, 2023 DelveInsight’s, “Still’s Disease- Pipeline Insight, 2023” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Still’s Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage pr ... Read More

    • Cutaneous T-Cell Lymphoma (CTCL)- Pipeline Insight, 2023

      Cutaneous T-Cell Lymphoma (CTCL)- Pipeline Insight, 2023 DelveInsight’s, “Cutaneous T-Cell Lymphoma (CTCL)- Pipeline Insight, 2023” report provides comprehensive insights about 30+ companies and 35+ pipeline drugs in Cutaneous T-Cell Lymphoma pipeline landscape. It covers the pipeline drug profiles, ... Read More

    • Graves’ Disease- Pipeline Insight, 2023

      Graves’ Disease- Pipeline Insight, 2023 DelveInsight’s, “Graves’ Disease- Pipeline Insight, 2023” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Graves’ Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage pro ... Read More

15 16 17 18 19 20 21 22 23 24

Cookie Settings